Skip to main content
. Author manuscript; available in PMC: 2022 Apr 20.
Published in final edited form as: Pediatr Blood Cancer. 2021 Feb 1;68(4):e28938. doi: 10.1002/pbc.28938

TABLE 3.

Summary for surgical management of paratesticular rhabdomyosarcoma: INSTRuCT consensus opinion document

Item Recommendation Quality Strength
Primary Inguinal Orchidectomy Remove paratesticular RMS by radical inguinal orchidectomy Moderate Strong
Remove the tumor as a single specimen incorporating the entire cord up to the internal ring and without breaching the tunica vaginalis High Strong
The cord should be clamped at the internal ring before mobilization of the tumor Low Weak
The cord is ligated using a non-absorbable suture Low Weak
When scrotal skin is fixed or grossly invaded by tumor, it should be resected en-bloc with the specimen High Strong
Testicle preserving approaches should be avoided High Strong
Primary Re-Excision
Primary re-excision (PRE) is indicated when the initial procedure did not include en-bloc complete gross resection of the tumor, testis and spermatic cord up to the internal ring Moderate Strong
Patients with microscopic residual disease after initial resection (IRS Group II) may undergo PRE when there is microscopic disease at the cord margin Moderate Strong
Management of Large Tumors
For large tumors that are difficult to excise through a standard inguinal incision, it is better to extend the inguinal incision down to the scrotum or use a combined inguinal and scrotal approach to facilitate a complete gross total tumor resection Moderate Strong
If there is proximal extension of the tumor through the inguinal canal, or extension into the urethra and base of the penis, the tumor is primarily irresectable and should be biopsied through an inguinal approach Low Strong
Trans-scrotal excision, scrotal violation, hemi-scrotectomy, scrotal RT A trans-scrotal approach to tumor resection should be avoided since it makes complete resection more difficult Moderate Strong
A trans-scrotal biopsy should be avoided since it may result in a potential increased risk of tumor spill Low Weak
Hemi-scrotectomy is not indicated if patients have a scrotal violation or microscopic residual disease (Clinical group II) present in the scrotum after gross tumor resection Low Weak
Scrotal skin should be removed en-bloc with the tumor excision if the tumor invades or extends into the scrotal skin High Strong
If scrotal RT is required due to Clinical group III disease, then temporary transposition of the remaining normal testis should be done to preserve function Moderate Strong
Retroperitoneal Lymph Node (RPLN) Assessment and Management
All patients ≥ 10 years old should undergo ipsilateral infrarenal surgical lymph node evaluation, regardless of imaging results, to identify patients with pathologic disease Moderate Strong
Patients <10 years old with no nodal enlargement should not undergo surgical RPLN evaluation given the low rate of pathologic nodal involvement High Strong
The rare patients who have alveolar histopathology, irrespective of age or tumor size, should undergo surgical nodal staging procedure Low Weak
Nodal sampling of 7-12 nodes from within the template area appears to be sufficient to identify disease presence Moderate Strong
Sentinel nodal evaluation, may be used to help identify the positive node. The patient should still have additional nodes sampled to achieve at least 7 RPLN Low Weak